RecruitingNCT07029841

Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong - the HONG KONG PECT Registry


Sponsor

Chinese University of Hong Kong

Enrollment

1,000 participants

Start Date

Jun 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This retrospective cohort study (Hong Kong PECT Registry) compares treatment outcomes between different percutaneous catheter-based therapies in patients with acute pulmonary embolism (PE). PE is a critical condition with potential for rapid deterioration and mortality before treatment. While availability of catheter-based therapy contributed to the declining mortality rates of PE, selecting the appropriate intervention remains key. There are primarily two modes of therapies available: Catheter-directed thrombolysis and Aspiration thrombectomy (e.g., Penumbra, Flowtriever, AlphaVac) Given limited direct comparisons between these methods, the study will evaluate their efficacy, safety, and clinical outcomes of these treatment strategies in acute PE patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients who is admitted with a diagnosis of acute pulmonary embolism
  • Patient who receives any types of catheter-based therapy for acute pulmonary embolism.

Exclusion Criteria1

  • nil. This is a all-comer registry.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEcatheter-based therapy

catheter-based therapy


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07029841


Related Trials